Intraoral neuropathy.
Chronic nonodontogenic toothache has been reported in the literature since the 1700s. This problem has followed a similar scenario since those first reports. The patient typically is misdiagnosed and then subjected to multiple unnecessary procedures, ultimately resulting in tooth extractions because of dentists and physicians being unaware of the existence of atypical odontalgia and other types of intraoral neuropathic pain that are treatable without sacrificing the teeth. This paper reviews the medications and procedures used to treat nonodontogenic toothache.
Merrill
Robert L
RL
School of Dentistry, University of California, Los Angeles, 10833 LeConte Avenue, Room 10-157, Box 951668, Los Angeles, CA 90024, USA. rmerrill@ucla.edu
D000927:Anticonvulsants / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D018756:GABA Antagonists / Q000627:therapeutic use*; D006801:Humans; D009055:Mouth / Q000503:physiopathology*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009619:Nociceptors / Q000502:physiology; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology*; D014098:Toothache / Q000188:drug therapy / Q000503:physiopathology
D000927:Anticonvulsants; D002121:Calcium Channel Blockers; D018756:GABA Antagonists; D018696:Neuroprotective Agents